MicroStrategy CEO Shifts From Kidney Joke to Selling Bitcoin Holdings
Michael Saylor pivoted from joking about selling a kidney to raising capital by selling Bitcoin holdings, reversing his earlier comments. The shift reduces MicroStrategy’s Bitcoin exposure and could signal pressure on its treasury management strategy.
1. Saylor Reverses Hyperbole and Plans Bitcoin Sale
Michael Saylor, co-founder and executive chairman of MicroStrategy, abandoned his previous quip about selling a kidney to fund operations and instead announced plans to liquidate a portion of the company’s Bitcoin holdings. This change highlights a more pragmatic approach to capital management, potentially affecting the firm’s overall cryptocurrency strategy and investor sentiment.
Related News
ODV
Osisko Development Raises US$275M via 4.125% Convertible Notes with 25% Premium
ODV•
GOOG
OpenAI Eyes Fall IPO After Lawsuit Win, Battling $900B Anthropic Rival
GOOG•
AMZN
Amazon MGM Invests $75M in Melania Documentary Despite Political Scrutiny
AMZN•
NVDA
Nvidia Targets $200 Billion Agentic AI Market with Vera CPU Launch
NVDA•
NVDA
Nvidia Raises Dividend to $0.25, Launches $80B Buyback after $91B Forecast
NVDA•
Sources
F